Solubility and thermodynamic study of mesalazine in propylene glycol+2-propanol mixtures

被引:4
作者
Poturcu, Kader [1 ,2 ]
Zarghampour, Aynaz [1 ,3 ]
Rahimpour, Elaheh [1 ,4 ]
Hemmati, Salar [5 ]
Zhao, Hongkun [6 ]
Jouyban, Abolghasem [1 ,7 ]
机构
[1] Tabriz Univ Med Sci, Fac Pharm, Pharmaceut Anal Res Ctr, Tabriz, Iran
[2] Suleyman Demirel Univ, Dept Chem Arts & Sci Fac, Isparta, Turkiye
[3] Tabriz Univ Med Sci, Student Res Comm, Fac Pharm, Tabriz, Iran
[4] Tabriz Univ Med Sci, Infect & Trop Dis Res Ctr, Tabriz, Iran
[5] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran
[6] YangZhou Univ, Coll Chem & Chem Engn, Yangzhou 225002, Jiangsu, Peoples R China
[7] Near East Univ, Fac Pharm, Mersin 10,POB 99138, Nicosia, North Cyprus, Turkiye
关键词
Mesalazine; Solubility; Cosolvency system; Dissolution thermodynamics; INFLAMMATORY-BOWEL-DISEASE; GLYCOL; RELEASE; CANCER;
D O I
10.1007/s43153-023-00306-1
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
In the current study, the solubility of mesalazine in the binary mixtures of propylene glycol (PG) + 2-propanol was determined using a shake flask method followed by UV-Vis spectroscopy method. The results showed that the maximum solubility was obtained in neat PG (x(m )= 4.57 x 10(- 4)) at 313.2 K and the minimum solubility in the neat 2-propanol (x(m )= 6.32 x 10(- 5)) at 293.2 K. In the next step, all data were fitted/back-calculated to several mathematical cosolvency models. Deviations of back-calculated data from experimental values (< 4.0%) show the applicability of the models for the prediction of solubility of meselazine in binary mixtures selected. For saturated systems, density data were also determined and fitted to the adopted form of the Jouyban-Acree model (back-calculated MRD% values were within 0.2%). Furthermore, the thermodynamic behavior of mesalazine in the PG + 2-propanol mixtures was investigated using the Gibbs energy, enthalpy, and entropy calculations at T-hm.
引用
收藏
页码:1227 / 1238
页数:12
相关论文
共 34 条
[1]   Solubility and thermodynamic properties of mesalazine in {2-propanol + water} mixtures at various temperatures [J].
Agha, Elnaz Mazaher Haji ;
Barzegar-Jalali, Mohammad ;
Adibkia, Khosro ;
Hemmati, Salar ;
Martinez, Fleming ;
Jouyban, Abolghasem .
JOURNAL OF MOLECULAR LIQUIDS, 2020, 301
[2]   Solubility of mesalazine in {1-propanol/water} mixtures at different temperatures [J].
Agha, Elnaz Mazaher Haji ;
Barzegar-Jalali, Mohammad ;
Adibkia, Khosro ;
Hemmati, Salar ;
Kuentz, Martin ;
Martinez, Fleming ;
Jouyban, Abolghasem .
JOURNAL OF MOLECULAR LIQUIDS, 2020, 301
[3]   Solubility of mesalazine in {acetonitrile+water} mixtures at various temperatures [J].
Barzegar-Jalali, Mohammad ;
Mazaher Haji Agha, Elnaz ;
Adibkia, Khosro ;
Hemmati, Salar ;
Martinez, Fleming ;
Jouyban, Abolghasem .
PHYSICS AND CHEMISTRY OF LIQUIDS, 2021, 59 (05) :690-705
[4]   Recent advances in mesalamine colonic delivery systems [J].
Bayan, Mohammad F. ;
Bayan, Rana F. .
FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 6 (01)
[5]   Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid [J].
Bernstein, CN ;
Eaden, J ;
Steinhart, AH ;
Munkholm, P ;
Gordon, PH .
INFLAMMATORY BOWEL DISEASES, 2002, 8 (05) :356-361
[6]   In Vitro Degradation and Drug-Release Properties of Water-Soluble Chitosan Cross-Linked Oxidized Sodium Alginate Core-Shell Microgels [J].
Chen, Chen ;
Liu, Mingzhu ;
Lu, Shaoyu ;
Gao, Chunmei ;
Chen, Jiucun .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2012, 23 (16) :2007-2024
[7]   Development and characterization of colon specific drug delivery system bearing 5-ASA and camylofine dihydrochloride for the treatment of ulcerative colitis [J].
Dubey, Rupal ;
Dubey, Rounak ;
Omrey, Pratibha ;
Vyas, S. P. ;
Jain, S. K. .
JOURNAL OF DRUG TARGETING, 2010, 18 (08) :589-601
[8]   Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis [J].
Feagan, Brian G. ;
MacDonald, John K. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (10)
[9]   ACUTE-PANCREATITIS DURING ORAL 5-AMINOSALICYLIC ACID THERAPY [J].
FIORENTINI, MT ;
FRACCHIA, M ;
GALATOLA, G ;
BARLOTTA, A ;
DELAPIERRE, M .
DIGESTIVE DISEASES AND SCIENCES, 1990, 35 (09) :1180-1182
[10]  
Grodowska K, 2010, ACTA POL PHARM, V67, P3